After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, KRON falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Kronos Bio Inc is $41.91M. A total of 0.51 million shares were traded on the day, compared to an average of 478.60K shares.
In the most recent transaction, BISCHOFBERGER NORBERT W bought 410,848 shares of KRON for 1.17 per share on Jun 27 ’24. After the transaction, the PRESIDENT & CEO now owns 10,597,468 company shares. In a previous transaction on Jun 28 ’24, BISCHOFBERGER NORBERT W bought 204,670 shares at 1.25 per share. KRON shares that PRESIDENT & CEO owns now total 10,802,138.
Among the insiders who bought shares, BISCHOFBERGER NORBERT W acquired of 1,378,901 shares on Jun 10 ’24 at a per-share price of $0.88. This resulted in the PRESIDENT & CEO holding 5,749,395 shares of KRON after the transaction. In another insider transaction, BISCHOFBERGER NORBERT W bought 881,913 shares at $1.24 per share on Jun 12 ’24. Company shares held by the PRESIDENT & CEO now total 7,375,616.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, KRON has a high of $1.60 and a low of $0.65.
As of this writing, KRON has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. KRON’s latest balance sheet shows that the firm has $339.51M in Cash & Short Term Investments as of fiscal 2021. There were $33.76M in debt and $13.63M in liabilities at the time. Its Book Value Per Share was $1.31, while its Total Shareholder’s Equity was $345.10M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KRON is Buy with a score of 5.00.
